260 related articles for article (PubMed ID: 33141777)
1. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
Duncan EM; Rodgers SE; McRae SJ
Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity.
Trossaërt M; Boisseau P; Quemener A; Sigaud M; Fouassier M; Ternisien C; Lefrançois-Bettembourg A; Tesson C; Thomas C; Bezieau S
J Thromb Haemost; 2011 Mar; 9(3):524-30. PubMed ID: 21166991
[TBL] [Abstract][Full Text] [Related]
4. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
Rodgers S; Duncan E
Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
[TBL] [Abstract][Full Text] [Related]
5. Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.
Strålfors A; Mikovic D; Schmidt D; Onelöv L; Soutari NMH; Berndtson M; Chaireti R; Holmström M; Antovic JP; Bruzelius M
Thromb Haemost; 2021 Jan; 121(1):27-35. PubMed ID: 32791533
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays.
Valikhani A; Mirakhorly M; Namvar A; Rastegarlari G; Toogeh G; Shirayeh FV; Ahmadinejad M
Transfus Apher Sci; 2021 Oct; 60(5):103194. PubMed ID: 34275734
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
Baig MA; Swamy KB
Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
[TBL] [Abstract][Full Text] [Related]
8. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
9. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
[TBL] [Abstract][Full Text] [Related]
10. One-stage vs. chromogenic assays in haemophilia A.
Potgieter JJ; Damgaard M; Hillarp A
Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
[TBL] [Abstract][Full Text] [Related]
12. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
Ingerslev J; Jankowski MA; Weston SB; Charles LA;
J Thromb Haemost; 2004 Apr; 2(4):623-8. PubMed ID: 15102018
[TBL] [Abstract][Full Text] [Related]
13. Assay discrepancy in mild haemophilia A.
Armstrong E; Hillarp A
Eur J Haematol Suppl; 2014 Aug; 76():48-50. PubMed ID: 24957107
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
[TBL] [Abstract][Full Text] [Related]
15. A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards.
Morfini M; Cinotti S; Bellatreccia A; Paladino E; Gringeri A; Mannucci PM;
J Thromb Haemost; 2003 Nov; 1(11):2283-9. PubMed ID: 14629459
[TBL] [Abstract][Full Text] [Related]
16. [Factor VIII assays in treated hemophilia A patients].
Lasne D; Pouplard C; Nougier C; Eschwege V; Le Cam Duchez V; Proulle V; Smahi M; Harzallah I; Voisin S; Toulon P; Sobas F; Galinat H; Flaujac C; Ternisien C; Jeanpierre E;
Ann Biol Clin (Paris); 2019 Feb; 77(1):53-65. PubMed ID: 30799298
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
Novembrino C; Boscolo Anzoletti M; Mancuso ME; Shinohara S; Peyvandi F
Haemophilia; 2019 May; 25(3):521-526. PubMed ID: 31044485
[TBL] [Abstract][Full Text] [Related]
18. Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.
Zwagemaker AF; Kloosterman FR; Gouw SC; Boyce S; Brons P; Cnossen MH; Collins PW; Eikenboom J; Hay C; Hengeveld RCC; Jackson S; Klopper-Tol CAM; Kruip MJHA; Gorkom BL; Male C; Nieuwenhuizen L; Shapiro S; Fijnvandraat K; Coppens M;
J Thromb Haemost; 2023 Apr; 21(4):850-861. PubMed ID: 36696222
[TBL] [Abstract][Full Text] [Related]
19. A critical appraisal of one-stage and chromogenic assays of factor VIII activity.
Peyvandi F; Oldenburg J; Friedman KD
J Thromb Haemost; 2016 Feb; 14(2):248-61. PubMed ID: 26663865
[TBL] [Abstract][Full Text] [Related]
20. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
